Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze (Q43709844)

26 November 2017

title

Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze (English)

1 reference

26 November 2017

1 reference

Z J Zhang

1

1 reference

26 November 2017

D E Schmidt

2

1 reference

26 November 2017

T de Paulis

3

1 reference

26 November 2017

B L Trivedi

4

1 reference

26 November 2017

E S Onaivi

5

1 reference

26 November 2017

M H Ebert

6

1 reference

26 November 2017

W A Hewlett

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Pharmacology, Biochemistry and Behavior

26 November 2017

published in

1 reference

26 November 2017

volume

69

1 reference

26 November 2017

issue

3-4

1 reference

26 November 2017

page(s)

571-578

1 reference

Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Current treatments of the anxiety disorders in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Behavioural studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Anxiolytic potential of 5-HT3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Zacopride: anxiolytic profile in rodent and primate models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Exploration of mice in a black and white test box: validation as a model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Evidence for central benzodiazepine receptor heterogeneity from behavior tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversive behavior to illumination and the von Bezold-Jarisch reflex in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Comparison of behavioral and central BDZ binding profile in three rat lines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Chronic nicotine reverses age-associated increases in tail-flick latency and anxiety in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Behavioral effects of (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

The pharmacotherapy of social phobia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Dexmedetomidine synergism with midazolam in the elevated plus-maze test in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Ondansetron in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

A fully automated light/dark apparatus useful for comparing anxiolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900566-4

7 January 2021

10.1016/S0091-3057(01)00566-4

Identifiers

DOI

1 reference

26 November 2017

1 reference